The global cardiology EHR market is valued at USD 3.52 billion in 2026 and is expected to reach USD 5.44 billion by 2035, growing at a 4.95% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Web/cloud-based EHR systems dominate the product segment, with ambulatory surgery centers expected to grow fastest by end-use category.

Software stocks plunged for an eighth consecutive session on Thursday, marking their longest losing streak since May 2021, as investors worry AI could undermine SaaS demand. Bitcoin fell 9% to $66,000, hitting 16-month lows, while commodities suffered broad declines. Major indices traded modestly lower, with notable losers including Estée Lauder (down 23% on tariff concerns), Palantir (down 4.4%), and Qualcomm (down 7% on weak guidance). Winners included McKesson (up 15.8%), Regal Rexnord (up 13%), and Uber (up 3%).

Medline Industries, the largest IPO of 2025, is positioned as an attractive investment opportunity. The Chicago-based medical supply company has demonstrated strong historical growth with 18% average annual sales growth since 1966 and 50 consecutive years of net sales growth. With a $375 billion total addressable market and solid free cash flow projections, analysts expect continued momentum, though the stock trades at a lofty P/E multiple of 28.

AOP Health US announced expanded distribution of Rapiblyk™ (landiolol), an FDA-approved ultra-short-acting beta-blocker for treating rapid heart rates in critical care settings. The drug is now available through four major pharmaceutical wholesalers: Cardinal, Cencora Specialty Distribution, McKesson Corporation, and Morris & Dickson, enhancing accessibility for hospitals and health systems nationwide.

Zuckerman Investment Group increased its Henry Schein stake by 72,040 shares in Q3, bringing its position to 281,339 shares valued at $18.67 million. The purchase reflects confidence in Henry Schein's improving fundamentals, including 5% revenue growth to $3.3 billion, 13% non-GAAP EPS growth to $1.38, and a new $200 million efficiency plan. The company also repurchased $229 million in stock during the quarter.

The global automated pharmacy compounding systems market is projected to grow from USD 2.95 billion in 2025 to USD 5.27 billion by 2035, driven by the need to reduce medication errors, demand for personalized medicine, and stringent regulatory standards.

Iterum Therapeutics reports expanding market access for ORLYNVAH™, securing nearly 25% insurance coverage in the U.S. and signing a Medicare Part D rebate agreement with a top Pharmacy Benefit Manager, with potential coverage starting in Q1 2026.

The global healthcare supply chain management market is projected to grow from $3.60 billion in 2025 to $9.20 billion by 2034, with a CAGR of 11.05%. North America leads the market, driven by technological advancements, AI integration, and demand for efficient healthcare logistics.

The Practice Management Systems market is expected to grow to $36.33 billion by 2031, with a 9.3% CAGR, driven by digital healthcare solutions, operational efficiency needs, and increasing telemedicine adoption.

The AI in Medical Billing Market is projected to grow from USD 3.69 billion in 2024 to USD 22.46 billion by 2032, driven by healthcare industry needs for automation, accuracy, and regulatory compliance.

Synergy CHC Corp reported its tenth consecutive quarter of profitability, with revenue of $8.1 million, a gross margin of 76.7%, and net income of $1.5 million. The company expanded its FOCUSfactor brand internationally and secured new North American retail distribution partnerships.

Five stocks are delivering strong total returns in 2025 by increasing their dividends by 10% or more, demonstrating commitment to shareholder value through consistent dividend growth and impressive stock performance.